Watch our webinar and download the report to explore how insights from ASCO 2022 can be used to better understand the hybrid congress experience, HCP perceptions and data-driven recommendations for future pharma engagement.
ASCO, the world’s most influential cancer conference, returned earlier this month, attracting more than 40,000 experts from around the globe – from cancer researchers and scientists to journalists and clinical trial specialists.
Held in person for the first time since the Covid-19 pandemic, the event resulted in an overwhelming spike in social network interactions. But which were the key conversation drivers and most mentioned products and topics? And how can pharma companies use social listening at future conferences and congresses to increase engagement?